GTCR Co-Invest XI LP's Form 4 filing
Sotera Health Co (SHC) · filed Nov 12, 2025
- Accession no.
- 0001193125-25-277915
- Filed
- Nov 12, 2025, 5:06 PM ET
- Trade date
- Nov 10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $187.8M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| GTCR Co-Invest XI LPCIK 0001591432 | Director, 10% Owner |
| GTCR Fund XI/A LPCIK 0001591434 | Director, 10% Owner |
| GTCR Fund XI/C LPCIK 0001591436 | Director, 10% Owner |
| GTCR Investment XI LLCCIK 0001827977 | Director, 10% Owner |
| GTCR Partners XI/A&C LPCIK 0001828028 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | Common Stock, $0.01 par value per share ("Common Stock") | SSaleDisposed | −12,000,000 | $15.65 | −$187,812,000 | 29,215,301 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.